Your browser doesn't support javascript.
loading
[The safety and efficacy of Firesorb bioresorbable scaffold in first-in-man study for coronary artery disease: the four-year outcomes].
Li, C J; Xu, B; Song, L; Yu, M Y; Yan, H B; Qiu, H; Mu, C W; Cui, J G; Guan, C D; Sun, Z W; Qiao, S B; Gao, R L.
Afiliação
  • Li CJ; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Xu B; Catheter Lab, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Song L; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Yu MY; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Yan HB; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Qiu H; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Mu CW; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Cui JG; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Guan CD; Catheter Lab, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Sun ZW; Catheter Lab, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Qiao SB; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
  • Gao RL; Department of Cardiology, Fuwai Hospital, National Cardiovascular Center, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
Zhonghua Xin Xue Guan Bing Za Zhi ; 49(2): 128-135, 2021 Feb 24.
Article em Zh | MEDLINE | ID: mdl-33611898
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fármacos Cardiovasculares / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fármacos Cardiovasculares / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article